54 related articles for article (PubMed ID: 2988762)
21. Selective displacement of nuclear proteins by antitumor drugs having affinity for nucleic acids.
Bartkowiak J; Kapuscinski J; Melamed MR; Darzynkiewicz Z
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5151-4. PubMed ID: 2525781
[TBL] [Abstract][Full Text] [Related]
22. Ternary interactions of spermine with DNA: 4'-epiadriamycin and other DNA: anthracycline complexes.
Williams LD; Frederick CA; Ughetto G; Rich A
Nucleic Acids Res; 1990 Sep; 18(18):5533-41. PubMed ID: 2216725
[TBL] [Abstract][Full Text] [Related]
23. Topoisomerases, new targets in cancer chemotherapy.
Zijlstra JG; de Jong S; de Vries EG; Mulder NH
Med Oncol Tumor Pharmacother; 1990; 7(1):11-8. PubMed ID: 2160032
[TBL] [Abstract][Full Text] [Related]
24. Bimodal induction of sister-chromatid exchanges by luminol, an inhibitor of poly(ADP-ribose) synthetase, during the S-phase of the cell cycle.
Ikushima T
Chromosoma; 1990 Sep; 99(5):360-4. PubMed ID: 2124964
[TBL] [Abstract][Full Text] [Related]
25. Aberrant DNA topoisomerase II activity, radioresistance and inherited susceptibility to cancer.
Cunningham JM; Francis GE; Holland MJ; Pirollo KF; Chang EH
Br J Cancer; 1991 Jan; 63(1):29-36. PubMed ID: 1846552
[TBL] [Abstract][Full Text] [Related]
26. Etoposide (VP-16-213)-induced gene alterations: potential contribution to cell death.
Berger NA; Chatterjee S; Schmotzer JA; Helms SR
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8740-3. PubMed ID: 1681541
[TBL] [Abstract][Full Text] [Related]
27. Intercalator-induced, topoisomerase II-mediated DNA cleavage and its modification by antineoplastic antimetabolites.
Zwelling LA; Silberman L; Estey E
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1041-7. PubMed ID: 2427489
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.
Zwelling LA; Kerrigan D; Michaels S
Cancer Res; 1982 Jul; 42(7):2687-91. PubMed ID: 6896293
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA
Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999
[TBL] [Abstract][Full Text] [Related]
30. Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells.
Pommier Y; Kerrigan D; Covey JM; Kao-Shan CS; Whang-Peng J
Cancer Res; 1988 Feb; 48(3):512-6. PubMed ID: 2825977
[TBL] [Abstract][Full Text] [Related]
31. Effects of dimethyl sulfoxide and thiourea upon intercalator-induced DNA single-strand breaks in mouse leukemia (L1210) cells.
Pommier Y; Zwelling LA; Mattern MR; Erickson LC; Kerrigan D; Schwartz R; Kohn KW
Cancer Res; 1983 Dec; 43(12 Pt 1):5718-24. PubMed ID: 6416668
[TBL] [Abstract][Full Text] [Related]
32. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.
Pommier Y; Kerrigan D; Schwartz RE; Swack JA; McCurdy A
Cancer Res; 1986 Jun; 46(6):3075-81. PubMed ID: 3009009
[TBL] [Abstract][Full Text] [Related]
33. Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells.
Pommier Y; Zwelling LA; Kao-Shan CS; Whang-Peng J; Bradley MO
Cancer Res; 1985 Jul; 45(7):3143-9. PubMed ID: 2988762
[TBL] [Abstract][Full Text] [Related]
34. The contribution of DNA single-strand breaks to the formation of chromosome aberrations and SCEs.
Speit G; Hochsattel R; Vogel W
Basic Life Sci; 1984; 29 Pt A():229-44. PubMed ID: 6085260
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]